Please login to the form below

Not currently logged in

Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

ViiV Healthcare

A rapid round up of news from pharma, biotech and healthcare

Better times ahead, promises AZ as Crestor drop outweighs new drugs

Pascal Soriot - AstraZeneca CEOPatent expiry fading says Soriot, as oncology prospects look good

FDA ‘names and shames’ generic-blocking pharma companies

Scott GottliebCelgene and Actelion top the list of offenders

Janssen named ‘Pharma Company of the Year’ at business intelligence awards

Adelphi Research takes home ‘Agency of the year’ trophy

Daily Brief: Immunotherapy combos dominate ASCO, Pharma's Brexit warning, Big data and prostate cancer

ASCO17News from the frontline of pharma, biotech and healthcare

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

Alex AzarNews from the frontline of healthcare, pharma and biotech

Trio depart Reynolds-MacKenzie to set up new comms agency

Experienced trio have launched new company akt health communications

Trump pledges ‘total victory’ in war on drug prices

Trump on drug pricesDespite rhetoric against pharma and PBMs, shares rise as markets shrug off threats to sector

Ashfield welcomes second intake of medical writers

Ashfield Healthcare CommunicationsNew recruits join the programme

citiesThe new basics

Innovative products and creative marketing won’t help if our industry fails to address the new basics

Featured jobs

Subscribe to our email news alerts


Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....